The future role of CD4 cell count for monitoring antiretroviral therapy
- 1 February 2015
- journal article
- editorial
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 15 (2) , 241-247
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort StudiesPLOS Medicine, 2013
- Challenges and opportunities for the implementation of virological testing in resource‐limited settingsJournal of the International AIDS Society, 2012
- Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible SolutionsJournal of Immunology Research, 2012
- Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysisBulletin of the World Health Organization, 2011
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011
- Clinical Outcome of HIV-Infected Patients with Discordant Virological and Immunological Response to Antiretroviral TherapyThe Journal of Infectious Diseases, 2011
- Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained SettingsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South AfricaClinical Infectious Diseases, 2009
- Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDSAIDS, 2009
- Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesThe Lancet, 2008